These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24713315)

  • 1. Pharmacotherapy of treatment-resistant schizophrenia: a clinical perspective.
    Dold M; Leucht S
    Evid Based Ment Health; 2014 May; 17(2):33-7. PubMed ID: 24713315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for dosing and switching antipsychotics for optimal clinical management.
    Buckley PF; Correll CU
    J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trials.
    Dold M; Li C; Gillies D; Leucht S
    Eur Neuropsychopharmacol; 2013 Sep; 23(9):1023-33. PubMed ID: 23602690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guideline for the pharmacotherapy of treatment-resistant schizophrenia. Royal College of Psychiatrists of Thailand.
    Disayavanish C; Srisurapanont M; Udomratn P; Disayavanish P; Kasantikul D; Netrakom P; Ngamtipwatthana T; Phornchirasilp S; Rangseekajee P; Samuthrsindh P; Sukanich P; Thiam-Kaew K; Visanuyothin T
    J Med Assoc Thai; 2000 Jun; 83(6):579-89. PubMed ID: 10932483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of aripiprazole with low-dose clozapine.
    Stoner SC; Dahmen MM; Berges A; Petry WM
    Pharmacotherapy; 2007 Nov; 27(11):1599-602. PubMed ID: 17963467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists.
    Correll CU; Brevig T; Brain C
    BMC Psychiatry; 2019 Nov; 19(1):362. PubMed ID: 31727015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose lamotrigine augmentation therapy improves residual symptoms in treatment-resistant schizophrenia: a report of five cases.
    Ohnuma T; Takebayashi Y; Higashiyama R; Shibata N; Arai H
    Asia Pac Psychiatry; 2013 Dec; 5(4):336-43. PubMed ID: 24591092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.
    Zink M; Knopf U; Henn FA; Thome J
    Pharmacopsychiatry; 2004 Jan; 37(1):26-31. PubMed ID: 14750045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antipsychotic drug combinations in the treatment of schizophrenia. A review of the literature].
    Gazdag G; Tolna J; Bitter I
    Neuropsychopharmacol Hung; 2012 Sep; 14(3):189-95. PubMed ID: 22987732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for transitioning therapy to aripiprazole from other antipsychotics in schizophrenia.
    Wisniewski CS; Robert S
    Ann Pharmacother; 2012; 46(7-8):1097-104. PubMed ID: 22811346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole in treatment-refractory schizophrenia.
    Hsu WY; Lee CI; Chiu NY; Kahn DA
    J Psychiatr Pract; 2009 May; 15(3):221-6. PubMed ID: 19461396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychopharmacological treatment of treatment-resistant schizophrenia].
    Lublin HK
    Ugeskr Laeger; 1997 Nov; 159(48):7128-33. PubMed ID: 9417718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing nonresponse in schizophrenia.
    Kane JM
    J Clin Psychiatry; 2012 Feb; 73(2):e07. PubMed ID: 22401484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based pharmacotherapy of treatment-resistant unipolar depression.
    Dold M; Kasper S
    Int J Psychiatry Clin Pract; 2017 Mar; 21(1):13-23. PubMed ID: 27848269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacotherapy of schizophrenia].
    Kovacs G
    Neuropsychopharmacol Hung; 2011 Dec; 13(4):239-47. PubMed ID: 22184193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.